Rice Hall James & Associates LLC Sells 8,201 Shares of Mesa Laboratories, Inc. $MLAB

Rice Hall James & Associates LLC lowered its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 32.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,145 shares of the medical instruments supplier’s stock after selling 8,201 shares during the period. Rice Hall James & Associates LLC owned about 0.31% of Mesa Laboratories worth $1,149,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Mesa Laboratories by 4.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,068 shares of the medical instruments supplier’s stock worth $364,000 after purchasing an additional 143 shares during the last quarter. Franklin Resources Inc. boosted its stake in Mesa Laboratories by 5.5% in the 2nd quarter. Franklin Resources Inc. now owns 3,476 shares of the medical instruments supplier’s stock worth $328,000 after purchasing an additional 182 shares during the period. American Century Companies Inc. boosted its position in shares of Mesa Laboratories by 1.5% in the second quarter. American Century Companies Inc. now owns 13,431 shares of the medical instruments supplier’s stock valued at $1,265,000 after acquiring an additional 194 shares during the period. CWM LLC lifted its stake in Mesa Laboratories by 48.9% in the 3rd quarter. CWM LLC now owns 597 shares of the medical instruments supplier’s stock worth $40,000 after purchasing an additional 196 shares in the last quarter. Finally, State of Alaska Department of Revenue boosted its holdings in Mesa Laboratories by 7.1% in the 2nd quarter. State of Alaska Department of Revenue now owns 3,224 shares of the medical instruments supplier’s stock valued at $303,000 after purchasing an additional 213 shares during the period. 90.60% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

MLAB has been the topic of several research analyst reports. Wells Fargo & Company upped their price target on shares of Mesa Laboratories from $75.00 to $83.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Wall Street Zen upgraded Mesa Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Weiss Ratings reiterated a “sell (d)” rating on shares of Mesa Laboratories in a research report on Wednesday, October 8th. Finally, Zacks Research raised Mesa Laboratories to a “strong sell” rating in a report on Thursday, December 11th. One equities research analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Sell” and an average price target of $83.00.

Mesa Laboratories Price Performance

MLAB opened at $80.47 on Friday. The company has a current ratio of 2.02, a quick ratio of 1.44 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $444.19 million, a P/E ratio of -251.47 and a beta of 0.90. The stock has a 50-day moving average price of $77.38 and a 200-day moving average price of $76.39. Mesa Laboratories, Inc. has a 12-month low of $55.45 and a 12-month high of $155.12.

Mesa Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 28th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Friday, November 28th. Mesa Laboratories’s dividend payout ratio (DPR) is presently -200.00%.

Mesa Laboratories Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.